BLEOMYCIN, created in 2000 (United States), from 1125 sister brands and 17477 competing brands. BLEOMYCIN is owned by Pfizer Inc, listed on the stock exchange of New York BLEOMYCIN belongs to the Drug Manufacturers business sector.
Investment simulator :
Portfolio valuation
Pfizer Inc
(BLEOMYCIN)
over 5 years*
USD 16.74